Keyphrases
Protective Effect
100%
Myocytes
100%
Multiple Signaling Pathways
100%
Levosimendan
100%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
55%
Extracellular Signal-regulated Kinase 1/2
44%
Mitochondrial KATP Channel
33%
Phosphorylation
22%
Ischemia-reperfusion Injury
22%
Akt Phosphorylation
22%
Oxygen Radicals
22%
Protein Kinase A Pathway
22%
Epidermal Growth Factor Receptor
22%
Signaling Pathway
11%
Protein Kinase
11%
Ischemia
11%
Cardioprotection
11%
Phosphodiesterase Inhibitors
11%
Pro-survival
11%
Beta-blockers
11%
Cell Viability
11%
Cardiovascular Drugs
11%
5-hydroxydecanoate
11%
Weight of Evidence
11%
Whole-heart Model
11%
Wiring
11%
Acute Decompensated Heart Failure
11%
Acute Heart Failure
11%
Neuroscience
Cell Signaling
100%
Myocyte
100%
Levosimendan
100%
P38 Mitogen-Activated Protein Kinases
55%
Extracellular Signal-Regulated Kinases
44%
Adenosine Triphosphate
33%
Protein Kinase A
33%
Free Radical
22%
Epidermal Growth Factor Receptor
22%
Ischemia
22%
Cyclic Adenosine Monophosphate
11%
Cell Viability
11%
Reperfusion Injury
11%
Phosphodiesterase Inhibitor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Levosimendan
100%
Mitogen Activated Protein Kinase P38
55%
Mitogen Activated Protein Kinase 3
44%
Cyclic AMP Dependent Protein Kinase
33%
Adenosine Triphosphate
33%
Ischemia
22%
Epidermal Growth Factor Receptor
22%
Oxygen Radical
22%
Reperfusion Injury
11%
Cell Viability
11%
Phosphodiesterase Inhibitor
11%
Congestive Heart Failure
11%
5 Hydroxydecanoic Acid
11%
Cardiovascular Agent
11%